Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice

Citation
A. De La Coste et al., Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice, CANCER RES, 59(19), 1999, pp. 5017-5022
Citations number
53
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
59
Issue
19
Year of publication
1999
Pages
5017 - 5022
Database
ISI
SICI code
0008-5472(19991001)59:19<5017:PIOCCB>2.0.ZU;2-1
Abstract
Here, we investigated changes in apoptosis during tumor progression by anal yzing the effect of coexpressing various antiapoptotic genes on the multist age process of c-myc-induced hepatocarcinogenesis in transgenic mice. Where as continuous c-myc gene overexpression in the liver led to cellular hepato carcinoma, the coexpression of the bcl-2 gene inhibited the emergence of li ver tumors, by inhibiting a pretumoral phase characterized by increased pro liferation and apoptosis. This antioncogenic effect was specific to Bcl-2 a nd was not shared by other antiapoptotic genes such as bcl-x(L) and a domin ant negative form of p53. Thus, we have shown that Bcl-2 can have a tumor s uppressor effect in vivo on c-myc-induced hepatocarcinogenesis during the e mergence of neoplastic foci.